Pelvic inflammatory disease: basic principles of therapy
https://doi.org/10.21518/2079-701X-2018-12-160-163
Abstract
Inflammatory diseases of the female genitals are an actual problem of obstetrics and gynaecology, as there is no tendency towards decline in the prevalence of these diseases despite improvements in treatment methods. An inadequate assessment of the severity of the infection process and an incorrectly chosen therapy scheme leads to the recurring chronic course.
About the Authors
V. L. Tyutyunnik
V.I. Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology of the Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
A. A. Veresova
V.I. Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology of the Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
E. A. Sirotkina
V.I. Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology of the Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
N. E. Kan
V.I. Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology of the Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
References
1. Rational pharmaco-therapy in obstetrics, gynecology and neonatology: A guide for practicing physicians. 2nd ed., Rev. and add. in 2 volumes. V. 1. Obstetrics, neonatology. Under the general editorship of Serova VN, Sukhikh GT. Moscow: Litterra, 2010, 784 p.
2. Shurshalina AV. Pelvic inflammatory diseases: modern tactics of therapy. Ginecologiya, 2011, 3 (5): 23-26.
3. Tikhomirov AL. The importance of adequate antibiotic therapy for pelvic inflammatory diseases to preserve reproductive health. Trudny Patsient, 2010, 8 (1-2): 9-12.
4. Haggerty CL, Ness RB. Diagnosis and treatment of pelvic inflammatory disease. Women’s Health, 2008, 4(4): 383-97.
5. Perlamutrov YuN, Chernova NI. Ways to improve the effectiveness of therapy for pelvic inflammatory diseases associated with mycoplasmal infection. Vestnik Dermatologii I Venerologii, 2011, 4: 102-106.
6. Savaris RF, Teixeira LM, Torres TG et al. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial. Obstetrics and Gynecology, 2007, 110(1): 53-60.
7. Prilepskaya V, Kisina V, Sokolovsky E, et al. On the issue of the role of mycoplasmas in urogenital pathology. Gynecologiya, 2007, 9: 31-38.
8. Short VL, Totten PA, Ness RB et al. Clinical presentation of Mycoplasma genitalium infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clinical Infectious Diseases, 2009, 48(1): 41-7.
9. Darville T. Recognition and treatment of chlamydial infections from birth to adolescence. Adv Exp Med Biol, 2013, 764: 109-22.
10. Mishori R, McClaskey EL, Winklerprins VJ. Chlamydia trachomatis infections: screening, diagnosis and management. Am Fam Physician, 2012, 86(12): 1127-32.
11. Rafalsky VV, Dovgan EV, Ostroumova MV. Approaches to the rational choice of antibacterial therapy for pelvic inflammatory diseases in women. Gynecologiya, 2010, 12 (3): 6-11.
12. Sethi S, Singh G, Samanta P, Sharma M. Mycoplasma genitalium: an emerging sexually transmitted pathogen. Indian J Med Res, 2012, 136(6): 942-55.
13. Hunjak B, Sabol I, Vojnović G et al. Ureaplasma urealyticum and Ureaplasma parvum in women of reproductive age. Arch Gynecol Obstet, 2014, 289(2): 407-12.
14. Dhawan B, Malhotra N, Sreenivas V et al. Ureaplasma serovars & their antimicrobial susceptibility in patients of infertility & genital tract infections. Indian J Med Res, 2012, 136(6): 991-6.
15. Zhou Y, Xu XL, Wang CP et al. Detection and the antibiotic susceptibility analysis of myco-plasma and chlamydia in urogenital tract infections of 327 cases patients with tubal infertility. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 2011, 25(3): 201-4.
16. Workowski KA, Berman SM. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep, 2010, 59(RR-12): 1-110.
17. Ross J, Judlin P, Nilas L. European guideline for the management of pelvic inflammatory disease. International Journal of STD and AIDS, 2007, 18(10): 662-66.
Review
For citations:
Tyutyunnik VL, Veresova AA, Sirotkina EA, Kan NE. Pelvic inflammatory disease: basic principles of therapy. Meditsinskiy sovet = Medical Council. 2018;(12):160-163. (In Russ.) https://doi.org/10.21518/2079-701X-2018-12-160-163
Views:
1143
Email this article 